1481 - 1490 of 5882 Results
Title
Year
- OnabotulinumtoxinA Dosing, Disease Severity, and Treatment Benefit in Patients With Cervical Dystonia: A Cohort Analysis From CD PROBE2022OPENTitle: OnabotulinumtoxinA Dosing, Disease Severity, and Treatment Benefit in Patients With Cervical Dystonia: A Cohort Analysis From CD PROBEJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.914486Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.914486/pdfCitation Count: 5
- Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism2022OPENTitle: Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonismJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 182Issue #:Start Page: 106338End Page: 106338Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.phrs.2022.106338Best OA location URL: http://manuscript.elsevier.com/S1043661822002833/pdf/S1043661822002833.pdfCitation Count: 8
-
OPENTitle: Geometric framework to predict structure from function in neural networksJournal Name: Physical Review ResearchPublisher: American Physical Society (APS)Vol: 4Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1103/physrevresearch.4.023255Best OA location URL: http://link.aps.org/pdf/10.1103/PhysRevResearch.4.023255Citation Count: 7
- Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease2022OPENTitle: Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 75End Page: 89Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.013Best OA location URL: http://www.prd-journal.com/article/S1353802022002048/pdfCitation Count: 14
- Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism2022OPENTitle: Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 39End Page: 42Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.019Citation Count: 0
- Telemedicine as an Untapped Opportunity for Parkinson’s Nurses Training in Personalized Care Approaches2022OPENTitle: Telemedicine as an Untapped Opportunity for Parkinson’s Nurses Training in Personalized Care ApproachesJournal Name: Journal of Personalized MedicinePublisher: MDPI AGVol: 12Issue #: 7Start Page: 1057End Page: 1057Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/jpm12071057Best OA location URL: https://www.mdpi.com/2075-4426/12/7/1057/pdf?version=1656473097Citation Count: 3
- Aromaticity at position 39 in α‐synuclein: A modulator of amyloid fibril assembly and membrane‐bound conformations2022OPENTitle: Aromaticity at position 39 in α‐synuclein: A modulator of amyloid fibril assembly and membrane‐bound conformationsJournal Name: Protein SciencePublisher: WileyVol: 31Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/pro.4360Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pro.4360Citation Count: 9
- Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease2022OPENTitle: Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s diseaseJournal Name: EJNMMI ResearchPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13550-022-00910-1Best OA location URL: https://ejnmmires.springeropen.com/counter/pdf/10.1186/s13550-022-00910-1Citation Count: 7
-
OPENTitle: Genetic prediction of impulse control disorders in Parkinson's diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 9Issue #: 7Start Page: 936End Page: 949Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51569Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268896Citation Count: 26
- Cholinergic brain network deficits associated with vestibular sensory conflict deficits in Parkinson’s disease: correlation with postural and gait deficits2022OPENTitle: Cholinergic brain network deficits associated with vestibular sensory conflict deficits in Parkinson’s disease: correlation with postural and gait deficitsJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 129Issue #: 8Start Page: 1001End Page: 1009Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-022-02523-3Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308723Citation Count: 13